Analysis of the CD95 ligand gene in 20 children with autoimmune lymphoproliferative syndrome (ALPS) [5]

Blood

Volumn 108, Issue 10, 2006, Pages 3622-3623

  Pauly, Eva ^a   Fritzsching, Benedikt ^b   Dechant, Markus ^b   Fellenberg, Joerg ^b   Scheuerpflug, Christian Gerold ^b   Debatin, Klaus Michael ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; LIGAND;

ACUTE LYMPHOCYTIC LEUKEMIA; APOPTOSIS; AUTOIMMUNE DISEASE; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENOMIC INSTABILITY; HOMOZYGOSITY; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33751182332     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-06-027995     Document Type: Letter

References (10)

1. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol. 2003;15:325-331.
2. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347-1349.
3. Wang J, Zheng L, Lobito A, et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999;98:47-58.
4. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935-946.
5. Wu J, Wilson J, He J, et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98:1107-1113.
6. Del-Rey M, Ruiz-Contreras J, Bosque A, et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood. 2006;108:1306-1312.
7. Kojima T, Horiuchi T, Nishizaka H, et al. Analysis of Fas ligand gene mutation in patients with systemic lupus erythematosus. Arthritis Rheum. 2000;43:135-139.
8. Kim HS, Lee SH, Lee JW, et al. Mutational analysis of Fas ligand gene in human non-Hodgkin lymphoma. APMIS. 2003;111:490-496.
9. Bolstad AI, Wargelius A, Nakken B, et al. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J Rheumatol. 2000;27:2397-2405.
10. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969-976.